Melanoma Incidence and Mortality in Europe

New Estimates, Persistent Disparities

A.M. Forsea; V. del Marmol; E. de Vries; E.E. Bailey; A.C. Geller


The British Journal of Dermatology. 2012;167(5):1124-1130. 

In This Article

Materials and Methods

Data Sources

Incidence and Mortality Estimates for Melanoma in 2008 GLOBOCAN 2008,[13] the standard set of worldwide estimates of cancer incidence and mortality produced by IARC for 2008, was used to provide the estimated incidence and mortality rates of melanoma in Europe.[13] Briefly, incidence and mortality rates for melanoma were estimated in GLOBOCAN 2008 by country, using the most recently available data collected at the IARC, or available in routine reports from the population-based cancer registries in Europe, and projecting them to 2008.[13] National incidence rates were estimated using different methods, depending on the availability and quality of data,[13] and are summarized in Table 1 . GLOBOCAN 2008 used age-standardized rates per 100 000 person-years based on the World Standard Population (age-standardized world rates).

Definition of Geographical Regions We used the classification of European countries in four geographical regions as defined by the United Nations (UN) and as used by GLOBOCAN 2008.[13] According to this classification, the European countries were grouped into the following regions:

CEE: Belarus, Bulgaria, Czech Republic, Hungary, Republic of Moldova, Poland, Romania, Russian Federation, Slovakia and Ukraine.

Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the U.K.

Southern Europe: Albania, Bosnia and Herzegovina, Croatia, Cyprus, Greece, Italy, Former Yugoslav Republic of Macedonia, Malta, Montenegro, Portugal, Serbia, Slovenia and Spain.

Western Europe: Austria, Belgium, France (metropolitan), Germany, Luxembourg, the Netherlands and Switzerland